Literature DB >> 12574961

Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura.

M Hino1, T Yamane, K Park, T Takubo, K Ohta, S Kitagawa, K Higuchi, T Arakawa.   

Abstract

The association between Helicobacter pylori ( H. pylori) infection and idiopathic thrombocytopenic purpura (ITP) has been reported by several groups. We investigated the prevalence of H. pylori infection and the effectiveness of its eradication in Japanese patients with ITP. H. pylori infection was found in 21 of 30 patients (70.0%) by (13)C urea breath test and presence of serum antibodies to H. pylori. H. pylori was eradicated in 18 of the 21 infected patients (85.7%) by administration of a proton pump inhibitor and two kinds of antibiotics. In only one patient was medication discontinued due to skin rash on the 4th day of treatment. Platelet recovery was obtained in ten patients (55.6%). In two patients with treatment failure, platelet recovery was obtained after successful re-eradication. In three patients without H. pylori infection, platelet counts did not significantly increase with the same treatment. On the other hand, eradication therapy did not affect platelet counts in patients with gastric ulcer. In conclusion, H. pylori eradication can be used for initial treatment with tolerable adverse effects in some ITP patients.

Entities:  

Mesh:

Year:  2002        PMID: 12574961     DOI: 10.1007/s00277-002-0579-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  12 in total

Review 1.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

Review 2.  Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 3.  Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review.

Authors:  Donald M Arnold; Ashley Bernotas; Ishac Nazi; Roberto Stasi; Masataka Kuwana; Yang Liu; John G Kelton; Mark A Crowther
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 4.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  Helicobacter pylori Eradication Therapy for Thrombocytopenia after Surgery for Abdominal Aortic Aneurysm with Disseminated Intravascular Coagulation.

Authors:  Takashi Ando; Daichi Akiyama; Hiroshi Okada; Kazuma Date; Hiroshi Furukawa; Makoto Takeda
Journal:  Ann Vasc Dis       Date:  2016-11-23

Review 6.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

7.  Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Authors:  Shannon C Jackson; Paul Beck; Andre G Buret; Pamela M O'Connor; Jonathan Meddings; Graham Pineo; Man-Chiu Poon
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

Review 8.  Helicobacter pylori and pregnancy-related disorders.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Tullia Todros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

9.  Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura.

Authors:  Erdal Kurtoglu; Ertugrul Kayacetin; Aysegul Ugur
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

10.  Clonally expanded T-cells in the peripheral blood of patients with idiopathic Thrombocytopenic purpura and Helicobacter pylori infection.

Authors:  Midori Ishiyama; Masanao Teramura; Koji Iwabe; Tomohiro Kato; Toshiko Motoji
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.